All registrations | Registrations with F7 as primary diagnosis excluded | |||||
---|---|---|---|---|---|---|
gPop | ID | ID vs gPop | gPop | ID | ID vs gPop | |
Median (5-95 %) | Median (5-95 %) | p | Median (5-95 %) | Median (5-95 %) | p | |
Inpatient | ||||||
All | 2 (1–13) | 2 (1–12) | 0.71 | 2 (1-13) | 2 (1–12) | 0.26 |
Women | 2 (1–11) | 2 (1–15) | 0.41 | 2 (1–11) | 2 (1–13) | 0.76 |
Men | 2 (1–14) | 2 (1–11) | 0.23 | 2 (1–14) | 1 (1–11) | 0.079 |
Outpatient | ||||||
All | 3 (1–23) | 4 (1–19) | 0.52 | 3 (1–23) | 3 (1-18) | 0.035 |
Women | 3 (1–24) | 4 (1–19) | 0.65 | 3 (1–24) | 3 (1–19) | 0.16 |
Men | 3 (1–21) | 3 (1–18) | 0.62 | 3 (1–21) | 3 (1–18) | 0.12 |
Total | ||||||
All | 3 (1–27) | 4 (1–22) | 0.35 | 3 (1–27) | 3 (1–21) | 0.016 |
Women | 3 (1–28) | 4 (1–21) | 0.43 | 3 (1–28) | 3 (1–20) | 0.12 |
Men | 3 (1–26) | 4 (1–22) | 0.58 | 2 (1–26) | 3 (1–21) | 0.064 |
LOS per visita | ||||||
All | 8 (1–45) | 12 (1–66) | 0.002 | 8 (1–45) | 11 (1-75) | 0.003 |
Women | 11 (1–45) | 12 (1–56) | 0.21 | 11 (1-45) | 13 (1–72) | 0.21 |
Men | 7 (1–45) | 11 (1–79) | 0.003 | 7 (1–45) | 11 (1–96) | 0.009 |
LOS for the study periodb | ||||||
All | 21 (1–167) | 23 (2-302) | 0.062 | 21 (1-167) | 21 (2-286) | 0.16 |
Women | 25 (1–176) | 26 (2–288) | 0.24 | 25 (1–176) | 26 (1–211) | 0.31 |
Men | 16 (2–167) | 19 (2–328) | 0.15 | 16 (2–167) | 18 (2–289) | 0.37 |